Colistin back as viable antibiotic for VAP

In this meta-analysis of studies that included colistin in the treatment of VAP, colistin was found to be as effective and as safe as control antibiotics. Given the limited antibiotic pipeline, colistin may be a reasonable alternative for VAP treatment in patients with limited antibiotic options (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment